Prostate Cancer Foundation - PCF-Pfizer Global Challenge Awards

The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Young Investigator Awards.

The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer. We continue to focus significant efforts on developing gifted cohorts of young prostate cancer researchers and are pleased to announce a new round of funding for PCF Young Investigators.

PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. This for example, includes funding “protected time” or direct costs for laboratory science. Every PCF Young Investigator is required to be under the direct supervision of a mentor. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Day, typically held in October, throughout the duration of their award and beyond.

We welcome applications from the global community. Applications are encouraged from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of prostate cancer. Applicants may be working in basic, translational, or clinical research and need not be trained specifically in prostate cancer science. However, successful applicants should be working in a research environment capable of supporting transformational prostate cancer research. Access to and interaction with a clinical environment and translational prostate cancer physician-scientists is highly desired.

Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients.

Veterans Administration (VA) Hospital Applicants and Projects
In order to improve the health and wellness of our treasured US military veterans, applicants with VA appointments are highly encouraged to apply. Projects that involve a Veterans Administration (VA) Hospital in their research proposal planning will be appreciated. This may include but is not limited to (1) creation of defined cohorts of prostate cancer patients annotated with the VA electronic medical record for the purpose of population science research; (2) blood, tissue or other body fluid specimens collection from VA prostate cancer patients for translational or clinical trial correlate research; (3) development of new biotechnologies for the diagnosis or treatment of prostate cancer patients within the VA system; (4) activation of novel IRB- and FDA-approved phase 1 and 2 clinical investigations; (5) unique genomic investigations of tumor or germline specimens from VA prostate cancer patients with the goal of understanding the unique mutations that might have occurred due to battlefield exposure to specific toxic materials; (6) precision medicine clinical trials matching pathogenic germline or tumor alterations to experimental or FDA-approved medications.

View and Download RFA

IMPORTANT: 

The online application submission portal will go live at https://pcf.smartsimple.com on Wednesday, February 1, 2017.

The deadline for application submission is Monday, March 13, 2017, 3:00 pm, Eastern Daylight Time (EDT).

Please direct questions to applications@pcf.org.